QurAlis
QurAlis is a biotechnology company developing treatments for amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).
3
Funding Rounds
$53.0m
Money raised
Funding
Funding series
Funding Series Analysis
The company QurAlis has raised a total of $47.5m in funding over 3 rounds.
Key Insights:
- QurAlis Series A round, May 2020: $42m
- QurAlis Seed round, November 2018: $5.5m
- QurAlis Corporation funding round, November 2018: $5.5m
QurAlis Series A round, May 2020
$42m
QurAlis Seed round, November 2018
$5.5m
QurAlis Corporation funding round, November 2018
$5.5m
Industries
QurAlis is active in the following industries: